TRCT
OYST

Tower Research Capital (TRC)’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Tower Research Capital (TRC)’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,861
Closed -$99K – 6767
2022
Q4 		$99K Sell
8,861
-32,050
-78% -$311K ﹤0.01% 1860
2022
Q3 		$230K Buy
40,911
+38,093
+1,352% +$239K ﹤0.01% 1792
2022
Q2 		$12K Buy
2,818
+1,898
+206% +$10.8K ﹤0.01% 4337
2022
Q1 		$11K Sell
920
-973
-51% -$11.6K ﹤0.01% 4253
2021
Q4 		$34K Buy
1,893
+335
+22% +$4.25K ﹤0.01% 3121
2021
Q3 		$19K Buy
1,558
+247
+19% +$3.6K ﹤0.01% 3789
2021
Q2 		$23K Buy
1,311
+352
+37% +$6.69K ﹤0.01% 3781
2021
Q1 		$18K Sell
959
-2,521
-72% -$52.9K ﹤0.01% 3981
2020
Q4 		$65K Sell
3,480
-2,570
-42% -$55.4K ﹤0.01% 2832
2020
Q3 		$128K Buy
6,050
+4,792
+381% +$112K ﹤0.01% 2944
2020
Q2 		$36K Buy
+1,258
New +$37.9K ﹤0.01% 3319
2020
Q1 		– Sell
-431
Closed -$11K – 4206
2019
Q4 		$11K Buy
+431
New +$7.57K ﹤0.01% 2307

Other funds holding OYST

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Tower Research Capital (TRC)'s OYST Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 8,861 shares — an estimated $99K sold.

Tower Research Capital (TRC) first reported a position in OYST in Q4 2019 and held it in 12 quarters. The position peaked at $230K in Q3 2022. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • Tower Research Capital (TRC) reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 8,861 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $99K.
  • Tower Research Capital (TRC) first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s Oyster Point Pharma, Inc. Common Stock position peaked at $230K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.